Life
Innovative CD40 Agonist Antibody Shows Systemic Cancer Reduction
A newly engineered CD40 agonist antibody, delivered via direct tumor injection, demonstrates potential for systemic cancer reduction in early trials, indicating significant implications for cancer treatment architecture.
Editorial Staff 21 days ago